Elliott Cuts Actelion Stake to Less Than 3%, Filing Shows

A UK affilliate of Elliott Management has trimmed its stake in a Swiss pharmaceutical company whose shares have flagged as speculation about a possible sale waned. (view story)

Advertisements

Comments are closed.